Shenzhen RuiJin Pharmaceutical Co.,Ltd 86-188-06592208 Gavin@hgh-steroid.com
TAM Pharmaceutical Grade Steroids Nolvadex Tamoxifen Citrate for Cancer Treatment

TAM Pharmaceutical Grade Steroids Nolvadex Tamoxifen Citrate for Cancer Treatment

  • High Light

    Pharmaceutical Raw Materials

    ,

    pharma raw material

  • Product name
    Tamoxifen Citrate
  • Other Name
    Nolvadex;TAM
  • CAS 
    54965-24-1
  • Molecular formula
    C26H29NO
  • Molecular weight
    371.51
  • Appearance
    White Powder
  • Usage
    Hormones And Regulation Of Endocrine Function Of Drug
  • Type
    Pharmaceutical Grade Steroids
  • Policy
    Re-sent Policy
  • Place of Origin
    China
  • Brand Name
    RuiiJin
  • Certification
    ISO9001
  • Model Number
    54965-24-1
  • Minimum Order Quantity
    10g
  • Price
    Negotiable
  • Packaging Details
    Disguised package or according to your requirement
  • Delivery Time
    Within 3-5 days
  • Payment Terms
    Western union and moneygram,Bank transfer,Bitcoin, T/T
  • Supply Ability
    3000t/month

TAM Pharmaceutical Grade Steroids Nolvadex Tamoxifen Citrate for Cancer Treatment

TAM Pharmaceutical Grade Steroids Nolvadex Tamoxifen Citrate for Cancer Treatment

 

Quick Detail:

 

  1. Tamoxifen Citrate
  2. Alias: Nolvadex;TAM
  3. CAS No: 54965-24-1
  4. Purity: 99%
  5. MF: C26H29NO
  6. MW: 371.51
  7. Einecs No: 234-118-0
  8. TAM Pharmaceutical Grade Steroids Nolvadex Tamoxifen Citrate for Cancer Treatment 0
  9. MOQ(minimum order quantity):10gram
  10. Standard: Enterprise Standard
  11. Appearance: white powder.

 

Benefits of Tamoxifen Citrate

 

1 . Estrogen blocker
2 . Boosts natural testosterone production
3 . Lesser risk of developing “gyno”
4 . Promotes liver health

 

 

 

How to dose Tamoxifen Citrate / Nolvadex ?

 

1. Usual Adult Dose for Breast Cancer:

 

For the treatment of metastatic breast cancer in women and men:
20 to 40 mg orally Dosages greater than 20 mg should be given in divided doses (morning and evening).

For the treatment of women with Ductal Carcinoma in Situ, following breast surgery and radiation:
20 mg orally daily for 5 years.

To reduce the incidence of breast cancer in women at high risk for breast cancer:
20 mg orally daily for 5 years.

 

2. Usual Adult Dose for Breast Cancer - Adjuvant:

 

For the treatment of node-positive breast cancer in postmenopausal women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation:
10 mg orally 2 to 3 times a day for 5 years.

 

3. Usual Adult Dose for Breast Cancer - Palliative:

 

10 to 20 mg orally twice a day

A beneficial response may not be evident for several months after initiation of therapy.

 

4. Usual Pediatric Dose for McCune-Albright Syndrome:

 

For use in girls age 2 to 10 years with McCune-Albright Syndrome and precocious puberty:
20 mg once a day. The duration of treatment is up to 12 months.

 

5. Usual Pediatric Dose for Precocious Puberty:

 

For use in girls age 2 to 10 years with McCune-Albright Syndrome and precocious puberty:
20 mg once a day. The duration of treatment is up to 12 months.

 

 

Side Effects

 

Loss of sexual ability/interest in men, depression, headache, hair thinning, swelling, fatigue, cough, muscle pain, bone pain, abdominal cramps, leg cramps, nausea, changes in menstrual periods, flushing, hot flashes.

 

 

Effects

 

As a nonsteroidal antiestrogen, Nolvadex is used to reduce the chances of breast cancer in high-risk patients, to treat breast cancer in certain patients after surgery and radiation therapy, and to treat breast cancer that has spread to other parts of the body (metastatic breast cancer).

 

Some symptoms such as vision problems or slurred speech; confusion; one-sided weakness; shortness of breath; coughing up blood; abnormal menstrual period; groin pressure or pain; chest pain; unusual vaginal bleeding or discharge, some of these events have been fatal.

For women, Nolvadex is used to decrease the risk of developing breast cancer have developed cancer of the uterus, stroke, and blood clots in the lung.​

 

The benefits of Nolvadex outweigh the risks in women who already have breast cancer. It's important to discuss the use of Nolvadex with doctor for the women at high risk of breast cancer or with ductal carcinoma in situ (DCIS). Decide if it's possible to reduce the risk of breast cancer outweigh the risk of these events.

 

TAM Pharmaceutical Grade Steroids Nolvadex Tamoxifen Citrate for Cancer Treatment 1